SGLT2 inhibitors and kidney outcomes in the real world

BMJ. 2020 Apr 29;369:m1584. doi: 10.1136/bmj.m1584.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Cohort Studies
  • Glucose
  • Hypoglycemic Agents
  • Kidney
  • Sodium
  • Sodium-Glucose Transporter 2 Inhibitors*
  • Symporters*

Substances

  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2 Inhibitors
  • Symporters
  • Sodium
  • Glucose